Funder
Fundação para a Ciência e a Tecnologia
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference51 articles.
1. Park KM, Lee BI, Shin KJ, Ha SY, Park J, Kim SE, et al. Efficacy, tolerability, and blood concentration of zonisamide in daily clinical practice. J Clin Neurosci. 2019;61:44–7.
2. Sano H, Nambu A. The effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice. Neurochem Int. 2019;124:171–80.
3. Iwaki H, Tagawa M, Iwasaki K, Kawakami K, Nomoto M. Comparison of zonisamide with non-levodopa, anti-Parkinson's disease drugs in the incidence of Parkinson's disease-relevant symptoms. J Neurol Sci. 2019;402:145–52.
4. Nishijima H, Miki Y, Ueno S, Tomiyama M. Zonisamide enhances motor effects of levodopa, not of Apomorphine, in a rat model of Parkinson's disease. Parkinson’s Dis. 2018;2018:8626783.
5. Limmer AL, Holland LC, Loftus BD. Zonisamide for cluster headache prophylaxis: a case series. Headache. 2019;59(6):924–9.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献